FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hervé Tilly

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Richard Delarue; Alain Delmer; Christophe Fermé; Olivier Fitoussi; Christophe Fruchart; Hervé Ghesquières; Maya Hacini; Corinne Haioun; Thierry Jo Molina; Nicolas Mounier; Tony Petrella; Gilles SALLES; Catherine Thieblemont; Antoine Thyss; Hervé Tilly; Achiel Van Hoof; Loïc Ysebaert; Serge Bologna; Olivier Casasnovas; André Bosly
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.
N Ketterer; Franck Morschhauser; Christian Récher; Carole Soussain; Catherine Thieblemont; Hervé Tilly; B Anglaret; Serge Bologna; C Bonnet; D Bordessoule; Josette Brière; Olivier Casasnovas; B Christian; Bertrand Coiffier; T Connerotte; R Delarue; Bettina Fabiani; Christophe Fermé; Christophe Fruchart; Corinne Haioun
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
Hervé Tilly; René-Olivier Casasnovas; Pierre Feugier; Corinne Haioun; Fabrice Jardin; T J Molina; F Morschhauser; G Salles; L Terriou; Bertrand Coiffier
Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hervé Tilly (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard Delarue; Alain Delmer; Christophe Fermé; Olivier Fitoussi; Christophe Fruchart; Hervé Ghesquières; Maya Hacini; Corinne Haioun; Thierry Jo Molina; Nicolas Mounier; Tony Petrella; Gilles SALLES; Catherine Thieblemont; Antoine Thyss; Hervé Tilly; Achiel Van Hoof; Loïc Ysebaert; Serge Bologna; Olivier Casasnovas; André Bosly
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.
The lancet oncology 2013;14(6):525-33.
2013: N Ketterer; Franck Morschhauser; Christian Récher; Carole Soussain; Catherine Thieblemont; Hervé Tilly; B Anglaret; Serge Bologna; C Bonnet; D Bordessoule; Josette Brière; Olivier Casasnovas; B Christian; Bertrand Coiffier; T Connerotte; R Delarue; Bettina Fabiani; Christophe Fermé; Christophe Fruchart; Corinne Haioun
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):1032-7.
2013: Hervé Tilly; René-Olivier Casasnovas; Pierre Feugier; Corinne Haioun; Fabrice Jardin; T J Molina; F Morschhauser; G Salles; L Terriou; Bertrand Coiffier
Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
Leukemia 2013;27(1):252-5.
2013: François Lefrère; Suzanne Mathieu-Nafissi; Jean-Michel Micléa; Nicolas Mounier; Gilles SALLES; Hervé Tilly; Olivier Hequet; Loic Isebaert; Valérie Lapierre; Dominique Bastit-Barrau; Alain Bohbot; Serge Bologna; Philippe Bourin; Christophe Fermé; Olivier Fitoussi; Luc Fornecker; Corinne Haioun
Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.
Transfusion 2013;53(1):115-22.
2012: David Sibon; Anne Sonet; Serge Bologna; Josette Brière; Bertrand Coiffier; Georges Delsol; Marion Fournier; Jean Gabarre; Philippe Gaulard; Christian Gisselbrecht; Corinne Haioun; Olivier Hermine; Laurence Lamant; Pierre Morel; Hervé Tilly
Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(32):3939-46.
2012: Marie-Hélène Delfau-Larue; Alain Delmer; Philippe Gaulard; Reda Bouabdallah; Pauline Brice; Olivier Casasnovas; Dominique Challine; Laurence de Leval; Richard Delarue; Bertrand Joly; Franck Morschhauser; Marie Parrens; Anne Plonquet; Gilles SALLES; Hervé Tilly; Corinne Haioun
Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.
Haematologica 2012;97(10):1594-602.
2012: Suzan Guney; Fabrice Jardin; Sylvain Mareschal; Françoise Parmentier; Jean-Michel Picquenot; Hervé Tilly; Philippe Bertrand; Christian Bastard
Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Genes, chromosomes & cancer 2012;51(9):858-67.
2012: Aspasia Stamatoullas; Hervé Tilly; Agathe Waultier; Celine Burgot; Marie Paule Callat; Fabrice Jardin; Françoise Parmentier; Dominique Penther; Christian Bastard
Development of a multiplex PCR assay for the detection of genomic copy number changes in myelodysplastic syndromes.
Leukemia research 2012;36(5):e93-7.
2012: Fabrice Jardin; Hervé Tilly
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone: until what age?
Leukemia & lymphoma 2012;53(4):521-2.
2012: E Launay; Céline Pangault; Karin Tarte; Hervé Tilly; Christian Bastard; Philippe Bertrand; Fabrice Jardin; Thierry Lamy; Thierry Fest
High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.
Leukemia 2012;26(3):559-62.
2011: Sylvain Mareschal; Philippe Ruminy; Hervé Tilly; Christian Bastard; Hélène Lanic; Fabrice Jardin
The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age.
Haematologica 2011;96(12):1888-90.
2011: Christian Récher; Gilles SALLES; Catherine Thiéblemont; Hervé Tilly; Serge Bologna; Christophe Bonnet; André Bosly; Danielle Canioni; Olivier Casasnovas; Bertrand Coiffier; Bernadette Corront; Christophe Fermé; Christophe Fruchart; Jean Gabarre; Hervé Ghesquières; Corinne Haioun; Jean-Philippe jais; Maud Janvier; Fabrice Jardin; Guy Laurent; Thierry Jo Molina; Franck Morschhauser
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Lancet 2011;378(9806):1858-67.
2011: Suzan Guney; Fabrice Jardin; Philippe Ruminy; Hervé Tilly; Jean Pierre Kerckaert; Philippe Bertrand; Christian Bastard
Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
Genes, chromosomes & cancer 2011;50(9):715-25.
2011: Olivier Fitoussi; Jean Gabarre; Hervé Ghesquieres; Bruno Anglaret; Karim Belhadj; Sabine Brechignac; Olivier Casasnovas; Christophe Ferme; Pierre Feugier; Corinne Haioun; Raoul Herbrecht; Maud Janvier; Franck Morschhauser; Nicolas Mounier; Marie Parrens; Gilles SALLES; Hervé Tilly; Eric Van Den Neste; Loic Ysebaert; Christian Gisselbrecht
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.
Haematologica 2011;96(8):1136-43.
2011: Steven Le Gouill; Lucie Planche; Gilles SALLES; Hervé Tilly; Achiel Van Hoof; Michel Blanc; Pauline Brice; Guillaume Cartron; Olivier Casasnovas; SOPHIE DE GUIBERT; Eric DECONINCK; Vincent Delwail; Jehan Dupuis; Olivier Fitoussi; Charles Foussard; Christophe Fruchart; Jean Gabarre; Lauris Gastaud; Rémy Gressin; Emmanuel Gyan
Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.
Haematologica 2011;96(8):1128-35.
2011: Romain Modzelewski; Hervé Tilly; Marie-Odile Habert; Didier Hannequin; Anne Hitzel; Stéphane Lepretre; Olivier Martinaud; Pierre Vera
Brain perfusion in adult patients with acute myeloblastic leukemia before and after cytosine arabinoside.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011;13(4):747-53.
2011: Fabrice Jardin; Philippe Ruminy; Francoise Parmentier; Xavier Troussard; Iona Vaida; Aspasia Stamatoullas; Stéphane Leprêtre; Dominique Penther; Anne B Duval; Jean-Michel Picquenot; Philippe Courville; Jean-Claude Capiod; Hervé Tilly; Christian Bastard; Jean P Marolleau
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm.
British journal of haematology 2011;153(3):413-6.
2011: Philippe Ruminy; P Etancelin; L Couronné; Françoise Parmentier; V Rainville; S Mareschal; E Bohers; C Burgot; M Cornic; Philippe Bertrand; Bernard Lenormand; Jean-Michel Picquenot; Fabrice Jardin; Hervé Tilly; Christian Bastard
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
Leukemia 2011;25(4):681-8.
2010: Fabrice Jardin; Jean-Philippe jais; Thierry Molina; Françoise Parmentier; Jean-Michel Picquenot; Philippe Ruminy; Hervé Tilly; Christian Bastard; Gilles-André Salles; Pierre Feugier; Catherine Thieblemont; Christian Gisselbrecht; Aurelien de Reynies; Bertrand Coiffier; Corinne Haioun; Karen Leroy
Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.
Blood 2010;116(7):1092-104.
2010: Hervé Tilly; M Dreyling
Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 5():v172-4.
2010: Emmanuel Bachy; Pauline Brice; Richard Delarue; Nicole Brousse; Corinne Haioun; Steven Le Gouill; Alain Delmer; Dominique Bordessoule; Hervé Tilly; Bernadette Corront; Christian Allard; Charles Foussard; André Bosly; Bertrand Coiffier; Christian Gisselbrecht; Philippe Solal-Celigny; Gilles SALLES
Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):822-9.
2009: Fabrice Jardin; Jean-Michel Picquenot; Françoise Parmentier; Philippe Ruminy; Marie Cornic; Dominique Penther; Philippe Bertrand; Hélène Lanic; Ophélie Cassuto; Catherine Humbrecht; Emilie Lemasle; Agathe Wautier; Christian Bastard; Hervé Tilly
Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.
British journal of haematology 2009;146(6):607-18.
2008: Franck Morschhauser; John Radford; Achiel Van Hoof; Umberto Vitolo; Pierre Soubeyran; Hervé Tilly; Peter C Huijgens; Arne Kolstad; Francesco d'Amore; Marcos Gonzalez Diaz; Mario Petrini; Catherine Sebban; Pier Luigi Zinzani; Marinus H J van Oers; Wim van Putten; Angelika Bischof Delaloye; Ama Rohatiner; Gilles SALLES; Jens Kuhlmann; Anton Hagenbeek
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5156-64.
2008: Philippe Ruminy; Fabrice Jardin; Jean-Michel Picquenot; Françoise Parmentier; Nathalie Contentin; Gérard Buchonnet; Sandrine Tison; Vinciane Rainville; Hervé Tilly; Christian Bastard
S(mu) mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells.
Blood 2008;112(5):1951-9.
2008: Catherine Sebban; Pauline Brice; Richard Delarue; Corinne Haioun; Bertrand Souleau; Nicolas Mounier; Nicole Brousse; Pierre Feugier; Hervé Tilly; Philippe Solal-Céligny; Bertrand Coiffier
Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3614-20.
2008: Fabrice Jardin; Philippe Ruminy; Jean-Pierre Kerckaert; Françoise Parmentier; Jean-Michel Picquenot; Sabine Quief; Céline Villenet; Gérard Buchonnet; Mario Tosi; Thierry Frebourg; Christian Bastard; Hervé Tilly
Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Haematologica 2008;93(4):543-50.
2008: Aude Marie-Cardine; Florence Divay; Ingrid Dutot; Alexa Green; Anne Perdrix; Olivier Boyer; Nathalie Contentin; Hervé Tilly; François Tron; Jean-Pierre Vannier; Serge Jacquot
Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation.
Clinical immunology (Orlando, Fla.) 2008;127(1):14-25.
2008: P Morel; Philippe Gaulard; C Gisselbrecht; Christophe Ferme; Gilles SALLES; Hervé Tilly; Josette Brière; M C Copin; Pierre Lederlin; Olivier Hermine; Ivan Theate; Corinne Haioun; Nicolas Mounier
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):560-5.
2008: Franck Morschhauser; J F Seymour; Hanneke C Kluin-Nelemans; A Grigg; M Wolf; M Pfreundschuh; Hervé Tilly; John M M Raemaekers; Mars B van 't Veer; Noël Milpied; G Cartron; A Pezzutto; A Spencer; F Reyes; M Dreyling
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):247-53.
2008: Hervé Tilly; Andrew D Zelenetz
Treatment of follicular lymphoma: current status.
Leukemia & lymphoma 2008;49 Suppl 1():7-17.
2008: Jean-Christophe Thery; Fabrice Jardin; Nathalie Massy; Jerome Massy; Aspasia Stamatoullas; Hervé Tilly
Optical neuropathy possibly related to arsenic during acute promyelocytic leukemia treatment.
Leukemia & lymphoma 2008;49(1):168-70.
2007: Christian Gisselbrecht; W Bethge; R F Duarte; ALESSANDRO MASSIMO GIANNI; Bertram Glaß; Corinne Haioun; G Martinelli; A Nagler; R Pettengell; A Sureda; Hervé Tilly; K Wilson
Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma.
Bone marrow transplantation 2007;40(11):1007-17.
2007: Pierre Vera; Matthieu John Ouvrier; Sébastien Hapdey; Marc Thillays; Anne Sophie Pesquet; Brigitte Diologent; F Callonec; Anne Hitzel; Agathe Edet-Sanson; Jean François Ménard; Fabrice Jardin; Hervé Tilly
Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?
European journal of nuclear medicine and molecular imaging 2007;34(12):1943-52.
2007: Carole Almire; Philippe Bertrand; Philippe Ruminy; Catherine Maingonnat; Iwona Wlodarska; José I Martín-Subero; Reiner Siebert; Hervé Tilly; Christian Bastard
PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)-positive peripheral T-cell lymphomas.
Genes, chromosomes & cancer 2007;46(11):1011-8.
2007: Silvia Montoto; C Canals; Ama Z S Rohatiner; Goli Taghipour; A Sureda; Norbert Schmitz; Christian Gisselbrecht; L Fouillard; Noël Milpied; C Haioun; S Slavin; E Conde; Christophe Fruchart; A Ferrant; V Leblond; Hervé Tilly; T A Lister; Anthony H Goldstone
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.
Leukemia 2007;21(11):2324-31.
2007: Aspasia Stamatoullas; Jean-Michel Picquenot; C Dumesnil; Philippe Ruminy; Dominique Penther; Philippe Bertrand; Marie-Noëlle Courel; C Maisonneuve; A François; Philippe Gaulard; Hervé Tilly; Christian Bastard
Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma.
Leukemia 2007;21(9):2064-7.
2007: Philippe Ruminy; Fabrice Jardin; Dominique Penther; Jean-Michel Picquenot; Françoise Parmentier; Gérard Buchonnet; Philippe Bertrand; Hervé Tilly; Christian Bastard
Recurrent disruption of the Imu splice donor site in t(14;18) positive lymphomas: a potential molecular basis for aberrant downstream class switch recombination.
Genes, chromosomes & cancer 2007;46(8):735-44.
2007: Christian Bastard; Gregory RAUX; Christophe Fruchart; Françoise Parmentier; D Vaur; Dominique Penther; X Troussard; D Nagib; Stéphane Lepretre; Mario Tosi; Thierry Frebourg; Hervé Tilly
Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patients.
Leukemia 2007;21(7):1460-3.
2007: Philippe Bertrand; Christian Bastard; Catherine Maingonnat; Fabrice Jardin; C Maisonneuve; Marie-Noëlle Courel; Philippe Ruminy; Jean-Michel Picquenot; Hervé Tilly
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Leukemia 2007;21(3):515-23.
2007: Christophe Bonnet; Georges Fillet; Nicolas Mounier; Gérard Ganem; Thierry Molina; Catherine Thiéblemont; Christophe Fermé; Bruno Quesnel; Claude Martin; Christian Gisselbrecht; Hervé Tilly; Felix Reyes
CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):787-92.
2007: Fabrice Jardin; Philippe Ruminy; Christian Bastard; Hervé Tilly
The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
Pathologie-biologie 2007;55(1):73-83.
2006: Fabrice Jardin; S S Sahota; Philippe Ruminy; Françoise Parmentier; Jean-Michel Picquenot; V Rainville; Gérard Buchonnet; S Leprêtre; Hervé Tilly; Christian Bastard
Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markers.
Leukemia 2006;20(11):2070-4.
2006: Aspasia Stamatoullas; Marie Paule Callat; Sandra Marreiros; Hervé Tilly; Christian Bastard
Unusual complex hyperdiploid karyotypes in myelodysplastic syndromes.
Cancer genetics and cytogenetics 2006;170(2):129-32.
2006: Catherine Sebban; Nicolas Mounier; Nicole Brousse; Coralie Belanger; Pauline Brice; Corinne Haioun; Hervé Tilly; Pierre Feugier; Reda Bouabdallah; Chantal Doyen; Gilles SALLES; Bertrand Coiffier
Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Blood 2006;108(8):2540-4.
2006: Philippe Ruminy; Fabrice Jardin; Jean-Michel Picquenot; Philippe Gaulard; Françoise Parmentier; Gérard Buchonnet; C Maisonneuve; Hervé Tilly; Christian Bastard
Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology.
Oncogene 2006;25(35):4947-54.
2006: Caroline Besson; Danielle Canioni; Eric Lepage; Stanislas Pol; Pierre Morel; Pierre Lederlin; Achiel Van Hoof; Hervé Tilly; Philippe Gaulard; Bertrand Coiffier; Christian Gisselbrecht; Nicole Brousse; Felix Reyes; Olivier Hermine
Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):953-60.
2005: Fabrice Jardin; Marc Vasse; Marc Debled; Stéphane Dominique; Philippe Courville; Françoise Callonnec; Gérard Buchonnet; Luc Thiberville; Hervé Tilly
Intense paraneoplastic neutrophilic leukemoid reaction related to a G-CSF-secreting lung sarcoma.
American journal of hematology 2005;80(3):243-5.
2005: Fabrice Jardin; Philippe Ruminy; Françoise Parmentier; Jean-Michel Picquenot; Marie-Noëlle Courel; Philippe Bertrand; Gérard Buchonnet; Hervé Tilly; Christian Bastard
Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma.
Leukemia 2005;19(10):1824-30.
2005: Fabrice Jardin; Philippe Courville; Pascal Lenain; Bernard Lenormand; Sophie Pouplin; Nathalie Contentin; Sophie Lehembre; Annie Laquerriere; Jean-François Clément; Hervé Tilly
Concomitant eosinophilia, fasciitis, and mycosis fungoides-like reaction with antinuclear autoantibodies in chronic myeloid leukaemia: role of a T-cell clone induced by imatinib.
The lancet oncology 2005;6(9):728-9.
2005: Pierre Feugier; Achiel Van Hoof; Catherine Sebban; Philippe Solal-Celigny; Reda Bouabdallah; Christophe Fermé; Bernard Christian; Eric Lepage; Hervé Tilly; Franck Morschhauser; Philippe Gaulard; Gilles SALLES; André Bosly; Christian Gisselbrecht; Felix Reyes; Bertrand Coiffier
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4117-26.
2005: Fabrice Jardin; Françoise Callonnec; Nathalie Contentin; Jean-Michel Picquenot; Isabelle Gueit; François Héron; Christian Bastard; Hervé Tilly
Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen.
Clinical lymphoma 2005;6(1):46-9.
2005: Adrienne de Labarthe; Cécile Pautas; Xavier Thomas; Stéphane de Botton; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Christian Bastard; Claude Preudhomme; Mauricette Michallet; Pierre Fenaux; Jean-Noël Bastie; Gérard Socié; Catherine Cordonnier; Hervé Dombret
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
Bone marrow transplantation 2005;35(8):767-73.
2005: Felix Reyes; Eric Lepage; Gérard Ganem; Thierry Molina; Pauline Brice; Bertrand Coiffier; Pierre Morel; Christophe Ferme; André Bosly; Pierre Lederlin; Guy Laurent; Hervé Tilly
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
The New England journal of medicine 2005;352(12):1197-205.
2005: Philippe Bertrand; Marie-Noëlle Courel; Catherine Maingonnat; Fabrice Jardin; Hervé Tilly; Christian Bastard
Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.
International journal of cancer. Journal international du cancer 2005;113(2):207-12.
2004: Nathalie Contentin; Pascal Lenain; P Chamouni; F Hau; D Bastit; Gérard Buchonnet; Hervé Tilly
Transient anti rhesus alloantibody produced by graft after non-myeloablative allogeneic stem cell transplant.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2004;31(3):191-7.
2004: François Lefrère; Vincent Lévy; Sylvie François; Richard Delarue; Norbert Ifrah; Hervé Tilly; Françoise Valensi; Xavier Troussard; Bruno Varet; Olivier Hermine
Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
Leukemia 2004;18(11):1924-5.
2004: Sylvie Castaigne; Sylvie Chevret; Eric Archimbaud; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Marc Simon; Brigitte Dupriez; Michel Renoux; Maud Janvier; Jean-Michel Micléa; Xavier Thomas; Christian Bastard; Claude Preudhomme; Francis Bauters; Laurent Degos; Hervé Dombret
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.
Blood 2004;104(8):2467-74.
2004: Lin Chen; Aspasia Stamatoullas; Christian Bastard; Hervé Tilly
Secondary Philadelphia chromosome in a patient with acute lymphoblastic leukemia.
Cancer genetics and cytogenetics 2004;152(2):132-5.
2004: Marc André; Nicolas Mounier; Xavier Leleu; Anne Sonet; Pauline Brice; Michel Henry-Amar; Hervé Tilly; Bertrand Coiffier; André Bosly; Pierre Morel; Corinne Haioun; Philippe Gaulard; Felix Reyes; Christian Gisselbrecht
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.
Blood 2004;103(4):1222-8.
2004: Pierre Feugier; jean-marc virion; Hervé Tilly; Corinne Haioun; Gérald Marit; Margaret Macro; Dominique Bordessoule; Christian Recher; M Blanc; Thierry Molina; Pierre Lederlin; Bertrand Coiffier
Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(1):129-33.
2003: Hervé Tilly; Eric Lepage; Bertrand Coiffier; Michel Blanc; Raoul Herbrecht; André Bosly; Michel Attal; Georges Fillet; Catherine Guettier; Thierry Molina; Christian Gisselbrecht; Felix Reyes
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
Blood 2003;102(13):4284-9.
2003: Karim Belhadj; Felix Reyes; Jean-Pierre Farcet; Hervé Tilly; Christian Bastard; Régis Angonin; Eric DECONINCK; Frédéric Charlotte; Veronique Leblond; Eric Labouyrie; Pierre Lederlin; Jean-Francois Emile; Béatrice Delmas-Marsalet; Bertrand Arnulf; Elie Serge Zafrani; Philippe Gaulard
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.
Blood 2003;102(13):4261-9.
2003: Bertrand Coiffier; Nicolas Mounier; Serge Bologna; Christophe Fermé; Hervé Tilly; Anne Sonet; Bernard Christian; Olivier Casasnovas; Eric Jourdan; Karim Belhadj; Raoul Herbrecht
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4402-6.
2003: Fabrice Jardin; Christian Bastard; Nathalie Contentin; Françoise Parmentier; Jean-Michel Picquenot; Hervé Tilly; Freda K Stevenson; Surinder S Sahota
Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma.
Blood 2003;102(5):1872-6.
2003: Nicolas Mounier; Josette Briere; Christian Gisselbrecht; Jean-Francois Emile; Pierre Lederlin; Catherine Sebban; Francoise Berger; André Bosly; Pierre Morel; Hervé Tilly; Reda Bouabdallah; Felix Reyes; Philippe Gaulard; Bertrand Coiffier
Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).
Blood 2003;101(11):4279-84.
2003: F Le Guillou; Stéphane Dominique; V Dubruille; Nathalie Contentin; Hervé Tilly; Georges Nouvet
[Acute respiratory distress syndrome due to pneumonitis following intrathecal methotrexate administration].
Revue des maladies respiratoires 2003;20(2 Pt 1):273-7.
2002: Fabrice Jardin; Gérard Buchonnet; Françoise Parmentier; Nathalie Contentin; S Leprêtre; Pascal Lenain; Jean-Michel Picquenot; Sophie Laberge-Le Couteulx; Philippe Bertrand; Aspasia Stamatoullas; J d'Anjou; Hervé Tilly; Christian Bastard
Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
Leukemia 2002;16(11):2318-25.
2002: Fabrice Jardin; Philippe Gaulard; Gérard Buchonnet; Nathalie Contentin; S Leprêtre; Pascal Lenain; Aspasia Stamatoullas; Jean-Michel Picquenot; C Duval; Françoise Parmentier; Hervé Tilly; Christian Bastard
Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
Leukemia 2002;16(11):2309-17.
2002: Nicole Girard; Catherine Maingonnat; Philippe Bertrand; Hervé Tilly; Jean-Pierre Vannier; Bertrand Delpech
Human monocytes synthesize hyaluronidase.
British journal of haematology 2002;119(1):199-203.
2002: Gérard Buchonnet; Fabrice Jardin; N Jean; Philippe Bertrand; Françoise Parmentier; S Tison; Stéphane Lepretre; Nathalie Contentin; Pascal Lenain; A Stamatoullas-Bastard; Hervé Tilly; Christian Bastard
Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?
Leukemia 2002;16(9):1852-6.
2002: Bruno Petitjean; Fabrice Jardin; Bertrand Joly; Nadine Martin-Garcia; Hervé Tilly; Jean-Michel Picquenot; Josette Brière; Claire Danel; Sylvie Mehaut; Issam Abd-Al-Samad; Christiane Copie-Bergman; Marie-Hélène Delfau-Larue; Philippe Gaulard
Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype.
The American journal of surgical pathology 2002;26(6):724-32.
2002: Christian Gisselbrecht; Eric Lepage; Thierry Molina; Bruno Quesnel; Georges Fillet; Pierre Lederlin; Bertrand Coiffier; Hervé Tilly; Jean Gabarre; Francoise Guilmin; Olivier Hermine; Felix Reyes
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2472-9.
2002: Stéphane Lepretre; Fabrice Jardin; Gérard Buchonnet; Pascal Lenain; Aspasia Stamatoullas; Ingrid Kupfer; Philippe Courville; Marie Paule Callat; Nathalie Contentin; Christian Bastard; Hervé Tilly
Eosinophilic leukemia associated with t(2;5)(p23;q31).
Cancer genetics and cytogenetics 2002;133(2):164-7.
2002: Bertrand Coiffier; Eric Lepage; Josette Briere; Raoul Herbrecht; Hervé Tilly; Reda Bouabdallah; Pierre Morel; Eric Van Den Neste; Gilles SALLES; Philippe Gaulard; Felix Reyes; Pierre Lederlin; Christian Gisselbrecht
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
The New England journal of medicine 2002;346(4):235-42.
2001: Jacques Bienvenu; R Chvetzoff; Gilles SALLES; C Balter; Hervé Tilly; Raoul Herbrecht; P Morel; Pierre Lederlin; Philippe Solal-Celigny; Bruno Audhuy; Bernard Christian; Jean Gabarre; Olivier Casasnovas; Gérald Marit; Catherine Sebban; Bertrand Coiffier
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(6):378-84.
2001: P Morel; B Souleau; Franck Morschhauser; A Duhamel; H Dombret; Hervé Tilly; Felix Reyes; Josette Brière; Bertrand Coiffier; P S Celigny; Eric Lepage; N Brousse
Assessing the Cox model assumption as a statistical tool for classifying lymphomas.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(5):341-51.
2001: André Bosly; Eric Lepage; Bertrand Coiffier; G Fillet; Raoul Herbrecht; Marine Divine; Brigitte Dupriez; C Nouvel; E Deconninck; Hervé Tilly; Dominique Bordessoule; Philippe Gaulard; Christian Gisselbrecht
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(4):279-85.
2000: Pauline Brice; D Simon; Reda Bouabdallah; C Bélanger; C Haïoun; C Thieblemont; Hervé Tilly; Jean-Luc Harousseau; Chantal Doyen; C Martin; Nicole Brousse; Philippe Solal-Céligny
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1585-90.
2000: Aspasia Stamatoullas; Gérard Buchonnet; Stéphane Lepretre; Pascal Lenain; Bernard Lenormand; C Duval; Marie Paule Callat; Philippe Gaulard; Christian Bastard; Hervé Tilly
De novo acute B cell leukemia/lymphoma with t(14;18).
Leukemia 2000;14(11):1960-6.
2000: Gérard Buchonnet; Pascal Lenain; Philippe Ruminy; Stéphane Lepretre; Aspasia Stamatoullas; Françoise Parmentier; Fabrice Jardin; C Duval; Hervé Tilly; Christian Bastard
Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3' BCL2 breakpoints and evidence of a new cluster.
Leukemia 2000;14(9):1563-9.
2000: Corinne Haioun; Eric Lepage; Christian Gisselbrecht; Gilles SALLES; Bertrand Coiffier; Pauline Brice; André Bosly; Pierre Morel; C Nouvel; Hervé Tilly; Pierre Lederlin; Catherine Sebban; Josette Brière; Philippe Gaulard; Felix Reyes
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):3025-30.
2000: Corinne Haioun; C Besson; Eric Lepage; Catherine Thieblemont; D Simon; C Rose; Hervé Tilly; Anne Sonet; Pierre Lederlin; M Attal; Josette Brière; Felix Reyes
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):685-90.
2000: François Lefrère; Olivier Hermine; Coralie Belanger; Sylvie François; Hervé Tilly; J C Lebas de La Cour; Françoise Valensi; Bruno Varet; Xavier Troussard
Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes.
Leukemia 2000;14(4):573-5.
2000: Hervé Tilly; Nicolas Mounier; Pierre Lederlin; Josette Brière; Brigitte Dupriez; Catherine Sebban; André Bosly; P Biron; C Nouvel; Raoul Herbrecht; Dominique Bordessoule; Bertrand Coiffier
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1309-15.
2000: Stéphane Lepretre; Gérard Buchonnet; Aspasia Stamatoullas; Pascal Lenain; C Duval; J d'Anjou; Marie Paule Callat; Hervé Tilly; Christian Bastard
Chromosome abnormalities in peripheral T-cell lymphoma.
Cancer genetics and cytogenetics 2000;117(1):71-9.
1999: Fabrice Jardin; Aspasia Stamatoullas; Gérard Buchonnet; C Duval; A Dujon; Jean-Michel Picquenot; Georges Nouvet; Hervé Tilly
[Primary pleural lymphoma after collapse therapy: modern aspects of an historic disease].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20(11):985-91.
1999: Bertrand Coiffier; E M Neidhardt-Bérard; Hervé Tilly; Coralie Belanger; Reda Bouabdallah; Corinne Haioun; Pauline Brice; Pierre-Yves Péaud; José-Luis Pico; Maud Janvier; Philippe Solal-Celigny; Nicole Brousse
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(10):1191-7.
1999: Didier Decaudin; Eric Lepage; Nicole Brousse; Pauline Brice; Jean-Luc Harousseau; Karim Belhadj; Hervé Tilly; L Michaux; S Chèze; Bertrand Coiffier; Philippe Solal-Céligny
Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2499-505.
1999: Xavier Thomas; Pierre Fenaux; Hervé Dombret; S Delair; François Dreyfus; Hervé Tilly; Anne Vekhoff; Pascale Cony-Makhoul; Véronique Leblond; Xavier Troussard; Catherine Cordonnier; Thierry de Revel; M Simon; Franck E Nicolini; Anne-Marie Stoppa; Maud Janvier; Dominique Bordessoule; Philippe Rousselot; Martine Ffrench; Jean-Pierre Marie; Eric Archimbaud
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).
Leukemia 1999;13(8):1214-20.
1999: Fabrice Jardin; Aspasia Stamatoullas; Christophe Fruchart; J d'Anjou; J F Clément; Hervé Tilly
[Intramedullary spinal cord metastasis and leptomeningeal involvement in Hodgkin's disease. Case report and review of the literature].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20(3):267-71.
1999: Eric Wattel; Eric Solary; B Hecquet; Denis Caillot; Norbert Ifrah; Annie Brion; Noël Milpied; Maud Janvier; Agnès Guerci; H Rochant; Catherine Cordonnier; François Dreyfus; A Veil; L Hoang-Ngoc; Anne-Marie Stoppa; Nicole Gratecos; Alain Sadoun; Hervé Tilly; Pauline Brice; Bruno Lioure; Bernard Desablens; Bernard Pignon; J P Abgrall; Michel Leporrier; Pierre Fenaux
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.
Advances in experimental medicine and biology 1999;457():35-46.
1999: M André; Michel Henry-Amar; José-Luis Pico; Pauline Brice; Didier Blaise; Mathieu Kuentz; Bertrand Coiffier; Philippe Colombat; Jean-Yves Cahn; Michel Attal; Joel Fleury; Noël Milpied; G Nedellec; Pierre Biron; Hervé Tilly; Jean-Pierre Jouet; Christian Gisselbrecht
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):222-9.
1998: Bertrand Coiffier; C Haioun; N Ketterer; Andreas Engert; Hervé Tilly; D Ma; P Johnson; Andrew Lister; M Feuring-Buske; John A Radford; R Capdeville; Volker Diehl; F Reyes
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.
Blood 1998;92(6):1927-32.
1998: Eric Wattel; Eric Solary; B Hecquet; Denis Caillot; Norbert Ifrah; Annie Brion; Béatrice Mahé; Noël Milpied; Maud Janvier; Agnès Guerci; H Rochant; Catherine Cordonnier; François Dreyfus; Agnès Buzyn; L Hoang-Ngoc; Anne-Marie Stoppa; Nicole Gratecos; Alain Sadoun; A Stamatoulas; Hervé Tilly; Pauline Brice; Frédéric Maloisel; Bruno Lioure; Bernard Desablens; Pierre Fenaux
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.
British journal of haematology 1998;102(4):1015-24.
1998: Christian Gisselbrecht; Philippe Gaulard; Eric Lepage; Bertrand Coiffier; Josette Brière; Corinne Haioun; Dominique Cazals-Hatem; André Bosly; L Xerri; Hervé Tilly; Françoise Berger; R Bouhabdallah; J Diebold
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).
Blood 1998;92(1):76-82.
1998: Nicolas Mounier; P Morel; Corinne Haioun; Bertrand Coiffier; Hervé Tilly; C Chatelain; Pierre Lederlin; A Thyss; Raoul Herbrecht; Christian Gisselbrecht; Eric Lepage
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.
Cancer 1998;82(10):1952-62.
1998: Corinne Haioun; Eric Lepage; Christian Gisselbrecht; Bertrand Coiffier; Chantal Doyen; P Morel; M Attal; Hervé Tilly; Eric DECONINCK; Philippe Gaulard; Felix Reyes
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 1():S5-8.
1998: Bernard Lenormand; marie bene; Jean-François Lesesve; Christian Bastard; Hervé Tilly; M P Lefranc; Gilbert Faure; Richard Garand; Annie Falkenrodt; G Kandel; Eric Solary; Marc Maynadié; Marie Paule Callat; F Thouret; M Monconduit; Jean-Pierre Vannier
PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies.
Leukemia & lymphoma 1998;28(3-4):329-42.
1997: Hervé Tilly; Philippe Gaulard; Eric Lepage; C Dumontet; J Diebold; I Plantier; F Berger; M Symann; Tony Petrella; Pierre Lederlin; Josette Brière
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.
Blood 1997;90(9):3727-34.
1997: Christophe Fruchart; Amar Salah; C Gray; E Martin; Aspasia Stamatoullas; Guy Bonmarchand; Jean-François Lemeland; Hervé Tilly
Lactobacillus species as emerging pathogens in neutropenic patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(9):681-4.
1997: Philippe Guardiola; Hélène Esperou; Dominique Cazals-Hatem; Norbert Ifrah; Jean-Pierre Jouet; Agnès Buzyn; L Sutton; Nicole Gratecos; Hervé Tilly; Bruno Lioure; Eliane Gluckman
Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation.
British journal of haematology 1997;98(4):1004-9.
1997: Y Bastion; Jean-Yves Blay; Marine Divine; Pauline Brice; Dominique Bordessoule; Catherine Sebban; Michel Blanc; Hervé Tilly; Pierre Lederlin; Eric DECONINCK; B Salles; Charles Dumontet; Josette Brière; Bertrand Coiffier
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2945-53.
1997: A François; Jean-François Lesesve; Aspasia Stamatoullas; François Comoz; Bernard Lenormand; Isabelle Etienne; I Mendel; J Hémet; Christian Bastard; Hervé Tilly
Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q.
The American journal of surgical pathology 1997;21(7):781-90.
1997: Christian Gisselbrecht; Corinne Haioun; Eric Lepage; Y Bastion; Hervé Tilly; André Bosly; Brigitte Dupriez; Gérald Marit; Raoul Herbrecht; Eric DECONINCK; Jean-Pierre Marolleau; A Yver; F Dabouz-Harrouche; Bertrand Coiffier; Felix Reyes
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
Leukemia & lymphoma 1997;25(3-4):289-300.
1997: Corinne Haioun; Eric Lepage; Christian Gisselbrecht; Y Bastion; Bertrand Coiffier; Pauline Brice; André Bosly; Brigitte Dupriez; C Nouvel; Hervé Tilly; Pierre Lederlin; P Biron; Josette Brière; Philippe Gaulard; Felix Reyes
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1131-7.
1997: Pauline Brice; Y Bastion; Eric Lepage; Nicole Brousse; C Haïoun; Philippe Moreau; N Straetmans; Hervé Tilly; I Tabah; Philippe Solal-Céligny
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1110-7.
1997: Aspasia Stamatoullas; Christophe Fruchart; S Khalfallah; Gérard Buchonnet; Nathalie Contentin; D Bastit; Hervé Tilly
Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age.
Bone marrow transplantation 1997;19(1):31-5.
1996: Agnès Guerci; Pierre Lederlin; F Reyes; Dominique Bordessoule; C Sebban; Hervé Tilly; Y Kerneis; P Biron; C Gisselbrecht; Raoul Herbrecht; Bertrand Coiffier
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(9):966-9.
1996: S Khalfallah; Aspasia Stamatoullas; Christophe Fruchart; F Proust; T Delangre; Hervé Tilly
Durable remission of a relapsing primary central nervous system lymphoma after autologous bone marrow transplantation.
Bone marrow transplantation 1996;18(5):1021-3.
1996: Christophe Fruchart; Bernard Lenormand; Christian Bastard; D Boulet; Jean-François Lesesve; Marie Paule Callat; Aspasia Stamatoullas; Mathieu Monconduit; Hervé Tilly
Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
American journal of hematology 1996;53(3):175-80.
1996: Aspasia Stamatoullas; Christophe Fruchart; D Bastit; D Boulet; M Moncondult; H Piguet; Hervé Tilly
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Cancer 1996;77(11):2302-7.
1996: Eric Archimbaud; V Leblond; Pierre Fenaux; Hervé Dombret; Catherine Cordonnier; François Dreyfus; Pascale Cony-Makhoul; Hervé Tilly; X Troussard; G Auzanneau; Xavier Thomas; Martine Ffrench; J P Marie
Timed sequential chemotherapy for advanced acute myeloid leukemia.
Hematology and cell therapy 1996;38(2):161-7.
1996: Philippe Solal-Céligny; Pauline Brice; Nicole Brousse; H Caspard; Y Bastion; C Haïoun; A Bosly; Hervé Tilly; Dominique Bordessoule; C Sebban; Jean-Luc Harousseau; P Morel; B Dupas; F Plassart; N Vasile; N Fort; M Leporrier
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):514-9.
1996: Marine Diviné; Eric Lepage; J Brière; P Pautier; Brigitte Dupriez; Pierre Lederlin; P Mineur; Hervé Tilly; M Blanc; Bruno Audhuy; Raoul Herbrecht; Bertrand Coiffier; Felix Reyes
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):240-8.
1995: Hervé Dombret; C Chastang; Pierre Fenaux; J Reiffers; Dominique Bordessoule; Reda Bouabdallah; F Mandelli; A Ferrant; G Auzanneau; Hervé Tilly
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
The New England journal of medicine 1995;332(25):1678-83.
1995: E Dallery; Sylvie Galiègue-Zouitina; M Collyn-d'Hooghe; Sabine Quief; Claude Denis; M P Hildebrand; Danièle Lantoine; C Deweindt; Hervé Tilly; Christian Bastard
TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation.
Oncogene 1995;10(11):2171-8.
1994: Sylvie Galiègue-Zouitina; M Collyn-d'Hooghe; Claude Denis; A Mainardi; M P Hildebrand; Hervé Tilly; Christian Bastard; Jean-Pierre Kerckaert
Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC.
Genes, chromosomes & cancer 1994;11(4):246-55.
1994: Corinne Haioun; Eric Lepage; Christian Gisselbrecht; Bertrand Coiffier; André Bosly; Hervé Tilly; P Morel; C Nouvel; Raoul Herbrecht; M F D'Agay
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2543-51.
1994: Jean-François Lesesve; Marie Paule Callat; Bernard Lenormand; Mathieu Monconduit; C Noblet; nicholas moore; F Caron; G Humbert; Aspasia Stamatoullas; Hervé Tilly
Hematological toxicity of ticlopidine.
American journal of hematology 1994;47(2):149-50.
1994: Hervé Tilly; A Rossi; Aspasia Stamatoullas; Bernard Lenormand; C Bigorgne; A Kunlin; Mathieu Monconduit; Christian Bastard
Prognostic value of chromosomal abnormalities in follicular lymphoma.
Blood 1994;84(4):1043-9.
1994: Sylvie Castaigne; Eric Archimbaud; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; M Simon; Brigitte Dupriez; G Auzanneau; Michel Legros; G Tertian
[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90].
Nouvelle revue française d'hématologie 1994;36 Suppl 2():S139-40.
1994: P Morel; Brigitte Dupriez; Raoul Herbrecht; Y Bastion; Hervé Tilly; A Delannoy; Corinne Haioun; C Nouvel; K Bouabdallah; E Baumelou
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
British journal of cancer 1994;70(1):154-9.
1994: Bernard Lenormand; M Bizet; Christophe Fruchart; Hervé Tilly; S Daliphard; F Thouret; C Canipel; Marie Paule Callat; H Piguet; Marie-Paule Lefranc
Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value.
Leukemia 1994;8(6):1019-26.
1994: Christian Bastard; C Deweindt; Jean-Pierre Kerckaert; Bernard Lenormand; A Rossi; F Pezzella; Christophe Fruchart; C Duval; Mathieu Monconduit; Hervé Tilly
LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients.
Blood 1994;83(9):2423-7.
1994: Christian Gisselbrecht; D Maraninchi; José-Luis Pico; Noël Milpied; Bertrand Coiffier; Marine Divine; P Tiberghien; A Bosly; Hervé Tilly; O Boulat
Interleukin-2 treatment in lymphoma: a phase II multicenter study.
Blood 1994;83(8):2081-5.
1993: Sylvie Castaigne; P Lefebvre; Christine Chomienne; E Suc; F Rigal-Huguet; Claude Gardin; Alain Delmer; Eric Archimbaud; Hervé Tilly; Maud Janvier
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia.
Blood 1993;82(12):3560-3.
1993: C Deweindt; Jean-Pierre Kerckaert; Hervé Tilly; Sabine Quief; V C Nguyen; Christian Bastard
Cloning of a breakpoint cluster region at band 3q27 involved in human non-Hodgkin's lymphoma.
Genes, chromosomes & cancer 1993;8(3):149-54.
1993: Jean-Pierre Kerckaert; C Deweindt; Hervé Tilly; Sabine Quief; G Lecocq; Christian Bastard
LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas.
Nature genetics 1993;5(1):66-70.
1993: Eric Lepage; Christian Gisselbrecht; Corinne Haioun; C Sebban; Hervé Tilly; André Bosly; P Morel; Raoul Herbrecht; Felix Reyes; Bertrand Coiffier
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(8):651-6.
1993: Eric Archimbaud; Pierre Fenaux; J Reiffers; Catherine Cordonnier; V Leblond; Philippe Travade; X Troussard; Hervé Tilly; G Auzanneau; J P Marie
Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.
Leukemia 1993;7(3):372-7.
1993: Bertrand Delpech; J P Vannier; Nicole Girard; M Bizet; A Delpech; Bernard Lenormand; Hervé Tilly; H Piguet
Expression of the hyaluronan-binding glycoprotein hyaluronectin in leukemias.
Leukemia 1993;7(2):172-6.
1993: Christian Gisselbrecht; André Bosly; Eric Lepage; Felix Reyes; T Philip; Corinne Haioun; Hervé Tilly; Bertrand Coiffier
Autologous hematopoietic stem cell transplantation in intermediate and high grade non-Hodgkin's lymphoma: a review.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4 Suppl 1():7-13.
1992: A Bosly; Bertrand Coiffier; Christian Gisselbrecht; Hervé Tilly; G Auzanneau; F Andrien; Raoul Herbrecht; Michel Legros; Y Devaux; Jérôme Jaubert
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1615-23.
1992: Gilles SALLES; Raoul Herbrecht; Pauline Brice; C Sebbań; Hervé Tilly; Pierre Lederlin; F Berger; Bertrand Coiffier
[Treatment of aggressive primary lymphomas of the digestive system by intensive chemotherapy. Experience of the Study Group on Lymphomas in Adults with the LNH-84 protocol].
Annales de gastroentérologie et d'hépatologie 1992;28(4):205-8.
1992: Christian Bastard; Hervé Tilly; Bernard Lenormand; C Bigorgne; D Boulet; A Kunlin; Mathieu Monconduit; H Piguet
Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma.
Blood 1992;79(10):2527-31.
1992: G Teixeira; Bernard Lenormand; P Jean; D Fardoun; E Sumereau-Dassin; D Bastit; Hervé Tilly; H Piguet; Mathieu Monconduit; Jean-Pierre Vannier
Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy.
American journal of hematology 1992;39(3):172-5.
1991: Bernard Lenormand; N Ghanem; Hervé Tilly; C Boussemart; Mathieu Monconduit; H Piguet; Gérard Lefranc; Marie-Paule Lefranc
Rearrangements of immunoglobulin light and heavy chain genes and correlation with phenotypic markers in B-cell chronic lymphocytic leukemia.
Leukemia 1991;5(11):928-36.
1991: Pierre Fenaux; G Tertian; Sylvie Castaigne; Hervé Tilly; G Leverger; H Guy; Dominique Bordessoule; R Leblay; E Le Gall; Philippe Colombat
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1556-61.
1991: Hervé Tilly; Christian Bastard; T Delastre; C Duval; M Bizet; Bernard Lenormand; J P Daucé; Mathieu Monconduit; H Piguet
Cytogenetic studies in untreated Hodgkin's disease.
Blood 1991;77(6):1298-304.
1991: Bertrand Coiffier; C Gisselbrecht; J M Vose; Hervé Tilly; Raoul Herbrecht; A Bosly; J O Armitage
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(2):211-9.
1991: Gilles SALLES; Raoul Herbrecht; Hervé Tilly; F Berger; N Brousse; C Gisselbrecht; Bertrand Coiffier
Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
The American journal of medicine 1991;90(1):77-84.
1990: Hervé Tilly; M Azagury; D Bastit; A Lallemand; H Piguet
Cyclosporin for treatment of life-threatening alloimmunization.
American journal of hematology 1990;34(1):75-6.
1990: Hervé Tilly; Sylvie Castaigne; Dominique Bordessoule; Philippe Casassus; Pierre-Yves Le Prisé; G Tertian; Bernard Desablens; Michel Henry-Amar; Laurent Degos
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(2):272-9.
1990: Sylvie Castaigne; Sylvie Chevret; Eric Lepage; françois guilhot; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; G Auzanneau; G Tertian; H Guy
Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients).
Nouvelle revue française d'hématologie 1990;32(5):297-300.
1989: F Lecomte; Hervé Tilly; G Grise; D Bastit; C Ropartz; J F Lemeland; G Humbert; M Monoconduit; H Piguet
[Preventive treatment of infection caused by gram-negative bacteria using anti-lipopolysaccharide antibodies. Evaluation in patients with aplasia].
Presse médicale (Paris, France : 1983) 1989;18(29):1419-22.
1989: Jean-Pierre Vannier; E Sumereau-Dassin; D Bastit; P Jean; Hervé Tilly; Mathieu Monconduit; H Piguet
Peripheral blood stem cells collected before and after leukapheresis in the very early remission phase of hematopoietic malignancies.
European journal of haematology 1989;42(5):481-6.
1988: Hervé Tilly; Christian Bastard; E Halkin; Bernard Lenormand; M Bizet; J P Dauce; O Lees; Mathieu Monconduit; H Piguet
Del(14)(q22) in diffuse B-cell lymphocytic lymphoma.
American journal of clinical pathology 1988;89(1):109-13.
1987: S Deharo; M Bizet; Mathieu Monconduit; Hervé Tilly; F Sari; H Piguet
[Spontaneous remission of refractory anemia with excess of blasts after septicemia].
Annales de médecine interne 1987;138(8):663-4.
1986: Hervé Tilly; Christian Bastard; M Bizet; H Piguet; S Castaigne; L Degos
Low-dose cytarabine: persistence of a clonal abnormality during complete remission of acute nonlymphocytic leukemia.
The New England journal of medicine 1986;314(4):246-7.
1985: Sylvie Castaigne; Hervé Tilly; F Sigaux; P Solal Celigny; Dominique Bordessoule; J Brière; Philippe Colombat; D Donadio; S Drony; H Guy
[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases].
Nouvelle revue française d'hématologie 1985;27(6):377-82.